| 1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-6.
|
| 2 |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| 3 |
Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011[J]. Chin J Cancer Res, 2015, 27(1): 2-12.
|
| 4 |
Oser MG, Niederst MJ, Sequist LV, et al. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin[J]. Lancet Oncol, 2015, 16(4): e165-e172.
|
| 5 |
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci USA, 2004, 101(9): 2999-3004.
|
| 6 |
Small EM, Frost RJ, Olson EN, et al. MicroRNAs and new dimension to cardiovascular disease[J]. Circulation, 2010, 121(8): 1022-1032.
|
| 7 |
Lai EC, Tomancak P, Williams RW, et al. Computational identification of Drosophila microRNA genes[J]. Genome Biol, 2003, 4(7): R42.
|
| 8 |
Lee I, Ajay SS, Yook JI, et al. New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites[J]. Genome Res, 2009, 19(7): 1175-1183.
|
| 9 |
Davalos V, Eeteller M. MicroRNAs and cancer epigenetics: a macroevolution[J]. Curr Opin Oncol, 2010, 22(1): 35-45.
|
| 10 |
Lin PY, Yu SL, Yang PC. MicroRNA in lung cancer[J]. Br J Cancer, 2010, 103(8): 1144-1148.
|
| 11 |
Calin GA, Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer, 2006, 6(11): 857-866.
|
| 12 |
Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol, 2008, 141(5): 672-675.
|
| 13 |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci USA, 2008，105(30): 10513-10518.
|
| 14 |
Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids[J]. Clin Chem, 2010, 56(11): 1733-1741.
|
| 15 |
Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers[J]. Med Res Rev, 2012, 32(2): 326-348.
|
| 16 |
Chen D, Guo W, Qiu Z, et al. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer[J]. Cancer Letters, 2015, 362(2): 208-217.
|
| 17 |
Huang P, Ye B, Yang Y, et al. MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2[J]. Tumour Biol, 2015, 36(5): 3381-3387.
|
| 18 |
Zhao G, Liu L, Zhao T, et al. Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer[J]. Tumor Biol, 2015, 36(5): 3693-3701.
|
| 19 |
Yang T, Thakur A, Chen T, et al. MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer[J]. Tumour Biol, 2015, 36(6): 4357-4365.
|
| 20 |
Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer[J]. Proc Natl Acad Sci USA, 2011, 108(9): 3713-3718.
|
| 21 |
Sozzi G, Boeri M, Rossi M, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study[J]. J Clin Oncol, 2014, 32(8): 768-773.
|
| 22 |
Zheng D, Haddadin S, Wang Y, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer[J]. Int J Clin Exp Pathol, 2011, 4(6): 575-586.
|
| 23 |
Heegaard NH, Schetter AJ, Welsh JA, et al. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer[J]. Int J Cancer, 2012, 130(6): 1378-1386.
|
| 24 |
Roth C, Stuckrath I, Pantel K, et al. Low levels of cell-free circulating miR-361-3p and miR-625-3p as blood-based markers for discriminating malignant from benign lung tumors[J]. PloS One, 2012, 7(6): e38248.
|
| 25 |
Bianchi F, Nicassio F, Marzi M, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer[J]. EMBO Mol Med, 2011, 3(8): 495-503.
|
| 26 |
Jiang M, Zhang P, Hu G, et al. Relative expressions of miR-205-5p，miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients[J]. Mol Cell Biochem, 2013, 383(1-2): 67-75.
|
| 27 |
Franchina T, Amodeo V, Bronte G, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced nonsmall cell lung cancer[J]. J Cell Physiol, 2014, 229(1): 97-99.
|
| 28 |
Sourvinou IS, Markou A, Lianidou ES. Quantification of circulating miRNAs in plasma：effect of preanalytical and analytical parameters on their isolation and stability[J]. J Mol Diagn, 2013, 15(6): 827-834.
|
| 29 |
Tafsiri E, Darbouy M, Shadmehr M B, et al. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features[J]. Tumour Biol, 2015, 36(3): 1603-1612.
|
| 30 |
Yang JS, Li BJ, Lu HW, et al. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening[J]. Tumour Biol, 2014, 36(4): 3035-3042.
|
| 31 |
Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer[J]. Lab Invest, 2011, 91(4): 579-587.
|
| 32 |
Zhou C, Chen Z, Dong J, et al. Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer[J]. Cancer Letters, 2015, 367(2): 138-146.
|
| 33 |
Xu LM, Li LQ, Li J, et al. Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues[J]. Chin Med J(Engl), 2015, 128(5): 670-673.
|
| 34 |
Jiang M, Zhang P, Hu G, et al. Relative expressions of miR-205-5p，miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients[J]. Mol Cell Biochem, 2013, 383(1-2): 67-75.
|
| 35 |
Mavridis K, Gueugnon F, Petit-Courty A, et al. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients：[J]. Br J Cancer, 2015, 112(9): 1527-1535.
|
| 36 |
张潍，张伟，王辉，等. miRNA-141、miRNA-145在非小细胞肺癌中的表达及与临床病理的关系[J]. 西安交通大学学报：医学版，2015(3): 368-372.
|
| 37 |
Zheng D, Haddadin S, Wang Y, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer[J]. Int J Clin Exp Pathol, 2011, 4(6): 575-586.
|
| 38 |
Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(10): 1721-1726.
|
| 39 |
Silva J, García V, Zaballos á，et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival[J]. Eur Respir J, 2011, 37(3): 617-623.
|
| 40 |
Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis[J]. J Cancer Res Clin Oncol, 2012, 138(12): 2045-2050.
|
| 41 |
Bai Y, Wang YL, Yao WJ, et al. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.[J]. Int J Clin Exp Pathol, 2015, 8(1): 824-829.
|
| 42 |
Ge H, Li B, Hu WX, et al. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival[J]. Int J Clin Exp Pathol, 2015, 8(1): 800-805.
|
| 43 |
Gao W, Lu X, Liu L, et al. MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer[J]．Cancer Biol Ther, 2012, 13(5): 330-340.
|
| 44 |
Shen Y, Tang D, Yao R, et al. microRNA expression profiles associated with survival，disease progression，and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation[J]. Med Oncol, 2013, 30(4): 750.
|
| 45 |
Franchina T, Amodeo V, Bronte G, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced nonsmall cell lung cancer[J]. J Cell Physiol, 2014, 229(1): 97-99.
|
| 46 |
Aushev VN, Zborovskaya IB, Laktionov KK, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma[J]. PLoS One, 2013, 8(10): e78649.
|